Literature DB >> 15265956

Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy.

Mohamed Elrefaei1, Michael D McElroy, Christopher P Preas, Rebecca Hoh, Steven Deeks, Jeffrey Martin, Huyen Cao.   

Abstract

A strong CD4(+) T cell response has been correlated with better control of HIV infection. However, the effect of HIV on the maintenance of Ag-specific memory CD4(+) T cells is not fully understood. We characterized the function and phenotype of memory CD4(+) T cells generated by mumps and influenza A or B viruses in HIV-infected individuals receiving highly active antiretroviral therapy (n = 21), HIV-infected long-term nonprogressors (n = 10), and HIV-seronegative volunteers (n = 10). We observed significantly decreased proliferation of the Ag-specific central memory CD4(+) T cell population (CD28(+)/CCR7(+)/CD45RA(-)) in the antiretroviral treated HIV-infected individuals compared with the seronegative controls. Restored CD4(+) T cell count and decreased HIV viral load while on highly active antiretroviral therapy did not result in increased proliferation, whereas nadir CD4(+) T cell count predicted the presence of Ag-specific proliferation. Our results indicate that HIV infection leads to impaired maintenance of virus-induced or vaccine-generated central memory CD4(+) T cells that is not restored by HAART.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265956     DOI: 10.4049/jimmunol.173.3.2184

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection.

Authors:  Enrique Espinosa; Christopher E Ormsby; Gustavo Reyes-Terán; Robert Asaad; Scott F Sieg; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  Functional impairment of CD4 T cells despite normalization of T cell number in HIV.

Authors:  Kenneth S Knox; Richard B Day; Lisa M Kohli; Chadi A Hage; Homer L Twigg
Journal:  Cell Immunol       Date:  2006-10-30       Impact factor: 4.868

3.  In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.

Authors:  Benigno Rodriguez; Hernan Valdez; Christoph G Lange; Robert Asaad; Kathy Medvik; Scott F Sieg
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

4.  Fatal pancreatitis in simian immunodeficiency virus SIV(mac251)-infected macaques treated with 2',3'-dideoxyinosine and stavudine following cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine 2,3-dioxygenase blockade.

Authors:  Monica Vaccari; Adriano Boasso; Claudio Fenizia; Dietmar Fuchs; Anna Hryniewicz; Tia Morgan; Deborah Weiss; Melvin N Doster; Jean Michel Heraud; Gene M Shearer; Genoveffa Franchini
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

5.  Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children.

Authors:  Kaitlin Rainwater-Lovett; Hope C Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn Bolton Moore; William J Moss
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-31       Impact factor: 2.205

6.  Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART.

Authors:  Kate Burgess; Patricia Price; Ian R James; Shelley F Stone; Niamh M Keane; Andrew Y F Lim; John R Warmington; Martyn A French
Journal:  J Clin Immunol       Date:  2006-03-28       Impact factor: 8.317

7.  A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy.

Authors:  Henri-Alexandre Michaud; Tiphanie Gomard; Laurent Gros; Kevin Thiolon; Roudaina Nasser; Chantal Jacquet; Javier Hernandez; Marc Piechaczyk; Mireia Pelegrin
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

8.  HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity.

Authors:  Nobuyuki Matoba; Adam S Husk; Brian W Barnett; Michelle M Pickel; Charles J Arntzen; David C Montefiori; Atsushi Takahashi; Kazunobu Tanno; Satoshi Omura; Huyen Cao; Jason P Mooney; Carl V Hanson; Haruo Tanaka
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

Review 9.  Impact of antiretroviral therapy on lung immunology and inflammation.

Authors:  Homer L Twigg; Kenneth S Knox
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

10.  Vaccination with SIVmac239Deltanef activates CD4+ T cells in the absence of CD4 T-cell loss.

Authors:  R K Reeves; J Gillis; F E Wong; R P Johnson
Journal:  J Med Primatol       Date:  2009-10       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.